Solubilized apyrases, methods and use
US12325870B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2019 |
| Grant date | Jun 10, 2025 |
| Priority date | — |
| Expiry date | Jul 17, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y306/01005
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are solubilized apyrase polypeptides, nucleotides encoding such solubilized apyrase polypeptides, pharmaceutical compositions containing such solubilized apyrase polypeptides, therapeutic uses of such solubilized apyrase polypeptides. Also provided herein are methods useful for preventing or treating tissue damage, e.g., by administering a solubilized apyrase polypeptide or pharmaceutical composition thereof, and methods for producing such solubilized apyrase polypeptides.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.